Hydroxychloroquine prevents resistance and potentiates antitumor effect of SHP2 inhibition in NF1-associated Malignant Peripheral Nerve Sheath Tumors
RNA-seq (gene expression) · mouse · 31 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 31 samples: 7 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumorsProceedings of the National Academy of Sciences of the United States of America · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE283902_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1195991 and SRA study SRP550320. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 7 replicated groups read from 31 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8674103 S5 S
- GSM8674104 S3 S
- GSM8674105 V2 V
- GSM8674106 V3 V
- GSM8674107 S2 S
- GSM8674108 S6 S
- GSM8674109 S4 S
- GSM8674110 S1 S
- GSM8674111 V1 V
- GSM8674112 PDX16-V2 PDX16-V
- GSM8674113 PDX16-S4 PDX16-S
- GSM8674114 PDX16-V3 PDX16-V
- GSM8674115 PDX16-V1 PDX16-V
- GSM8674116 PDX16-S3 PDX16-S
- GSM8674117 PDX16-S1 PDX16-S
- GSM8674118 PDX16-V4 PDX16-V
- GSM8674119 PDX16-S2 PDX16-S
- GSM8674120 Shp-21-Day-1 Shp-21-Day
- GSM8674121 VEH-5-Day-3 VEH-5-Day
- GSM8674122 Shp-21-Day-4 Shp-21-Day
- GSM8674123 VEH-5-Day-4 VEH-5-Day
- GSM8674124 Shp-5-Day-3 Shp-5-Day
- GSM8674125 VEH-5-Day-2 VEH-5-Day
- GSM8674126 Shp-5-Day-1 Shp-5-Day
- GSM8674127 Shp-21-Day-3 Shp-21-Day
- GSM8674128 Shp-21-Day-5 Shp-21-Day
- GSM8674129 Shp-5-Day-4 Shp-5-Day
- GSM8674130 VEH-5-Day-1 VEH-5-Day
- GSM8674131 Shp-21-Day-2 Shp-21-Day
- GSM8674132 Shp-5-Day-2 Shp-5-Day
- GSM8674133 Shp-21-Day-6 Shp-21-Day
- GSE312030 Combined inhibition of HRAS and MEK induces tumor regression and restores myogenic differentiation in HRAS-mutant rhabdomyosarcoma 159 samples same disease briefing · shares inhibition
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples same disease briefing · shares resistance
- GSE300974 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [RNA-seq] 30 samples same disease briefing · shares inhibition
- GSE228127 Multimodal single-cell profiling reveals the enhanced antitumor activity of FGFR4/CD276 BiCisCAR T cells in rhabdomyosarcoma 12 samples same disease briefing · shares antitumor
- GSE303028 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma 104 samples same disease briefing · shares inhibition
- GSE274640 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma. 80 samples same disease briefing · shares resistance
- GSE303151 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [CUT&RUN] 50 samples same disease briefing · shares inhibition
- GSE273952 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [Spatial Transcriptomics] 19 samples same disease briefing · shares resistance
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.